In summary, our study revealed that overexpression of miR-326 can inhibit cell proliferation, migration and invasion in prostate cancer cell line by regulating CKAP2L expression, which can be further investigated as a potential treatment target and a novel diagnosis marker. The gene discussed is CKAP2L; the disease is prostate carcinoma.